TEL
71
8
BIIB
45
6
LNC
69
7
CRM
59
7
NKE
39
9
NWS
100
2
C
79
7
AMAT
60
7
HRL
32
-6
EXPE
72
10
FLR
65
9
MLM
56
3
PRGO
39
2
HRB
63
2
COST
54
3
STI
15
-11
HPE
75
9
TGNA
62
3
IRM
55
3
NEM
56
-5
TEL
71
8
BIIB
45
6
LNC
69
7
CRM
59
7
NKE
39
9
NWS
100
2
C
79
7
AMAT
60
7
HRL
32
-6
EXPE
72
10
FLR
65
9
MLM
56
3
PRGO
39
2
HRB
63
2
COST
54
3
STI
15
-11
HPE
75
9
TGNA
62
3
IRM
55
3
NEM
56
-5
Financhill
Back

Rigel Pharmaceuticals Stock Predictions

Former Zillow execs target $1.3T market

This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Sell
44

RIGL
Rigel Pharmaceuticals

Last Price:
$17.78
Seasonality Move:
-1.01%

7 Day Trial

ALL ACCESS PASS

$ 7

The key to a $1.3T opportunity

This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.

Rigel Pharmaceuticals Stock Forecast

  • Over the next 52 weeks, Rigel Pharmaceuticals has on average historically risen by 0.4% based on the past 24 years of stock performance.
  • Rigel Pharmaceuticals has risen higher in 9 of those 24 years over the subsequent 52-week period, corresponding to a historical accuracy of 37.5%
  • Is Rigel Pharmaceuticals Stock Undervalued?
    The current Rigel Pharmaceuticals [RIGL] share price is $18.61. The Score for RIGL is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
  • RIGL is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Rigel Pharmaceuticals Stock Go Up Next Year?

  • Over the next 52 weeks, Rigel Pharmaceuticals has on average historically risen by 0.4% based on the past 24 years of stock performance.

Rigel Pharmaceuticals Stock Rating

Sell
44
Rigel Pharmaceuticals (RIGL) is a Sell

Is Rigel Pharmaceuticals overpriced?

  • Rigel Pharmaceuticals has risen higher in 9 of those 24 years over the subsequent 52-week period, corresponding to a historical accuracy of 37.5%

Rigel Pharmaceuticals Stock Price History

Is RIGL stock going to rise?

  • The current trend is relatively stagnant and RIGL is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
rigel.com

52-Week Data

52-Week High:
29.82
52-Week Low:
7.48

Prediction Charts

Market Cap:
332.6M
Price in USD:
18.61
Volume:
218K
Beta:
1.47

Technical Analysis

SMA50:
18.82
SMA100:
19.28
SMA200:
17.80
52-Wk Change:
89.05%

Stock Predictions

  • Is Rigel Pharmaceuticals stock public?
    Yes, Rigel Pharmaceuticals is a publicly traded company.
  • What is the Rigel Pharmaceuticals stock quote today?
    The Rigel Pharmaceuticals stock price is 18.61 USD today.
  • How to buy Rigel Pharmaceuticals stock online?
    You can buy Rigel Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Apr-23 18.04 18.16 19.01 18.04
Apr-24 18.24 19.06 19.11 18.14
Apr-25 18.78 19.28 19.49 18.35
Apr-28 19.25 19.41 19.61 18.88
Apr-29 19.50 19.57 19.86 19.11
Apr-30 19.15 19.54 19.65 19.00
May-1 19.50 18.72 19.56 18.64
May-2 18.97 19.36 19.52 18.90
May-5 19.01 19.11 19.45 18.70
May-6 18.99 18.26 18.99 17.89
May-7 22.55 18.47 25.42 18.00
May-8 18.47 18.90 19.09 16.88
May-9 18.83 18.77 19.75 18.50
May-12 19.02 18.61 19.74 18.44

Rigel Pharmaceuticals Earnings

Rigel Pharmaceuticals Earnings Report: Per Share Rigel Pharmaceuticals Earnings Q1 Q2 Q3 and Q4 last year and next year.

Rigel Pharmaceuticals Forecast Revenue Growth

Rigel Pharmaceuticals Stock Analysis: Historical quarterly revenues per share for Rigel Pharmaceuticals and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.18 per share, a decrease next quarter of $0.21 per share, an increase this year of $1.86 per share, and a decrease next year of $0.27 per share.

* Rigel Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.